期刊文献+

尼古丁对膀胱癌p53基因表达的相关研究 被引量:3

Correlative study of p53 expression influence by Nicotine in bladder cancer
下载PDF
导出
摘要 目的:探讨尼古丁与癌基因表达和膀胱癌生物学行为的关系。方法:对40 只大鼠以10% BBN为致癌剂膀胱灌注诱发膀胱癌,其中30只分25、15、5 mg/kg剂量以咽管灌胃方式给予尼古丁, 10 只作为对照,应用免疫组化方法对膀胱癌模型中p53蛋白进行检测。结果:不同剂量的尼古丁干预下的p53 蛋白表达的阳性率分别为60%、30%、20%。p53蛋白表达阳性率与给药剂量、给药时间呈正相关。结论:尼古丁对癌基因的异常表达及协同作用,在膀胱癌的发生发展中起一定作用。 Objective:Purpose: To explore the relationship between nicotine and the expression of oncogenes of bladder carcinoma and its biological characteristic. Methods:The expression of p53 proteins in 40 cases bladder carcinoma model of wistar rats was determined with immunohistochemistry. Results:The positive rate of expression for p53 proteins under the influence of nicotine in various dose were 60%, 30% and 20% respectively. The positive rate of expression for p53 proteins was positively correlated to medication dose and time. Conclusions:Abnormal expression and synergistic action of oncogenes and nicotine play an important role in occurrence and development of bladder carcinoma.
作者 潘峰 庞自力
出处 《临床泌尿外科杂志》 2005年第5期301-303,共3页 Journal of Clinical Urology
关键词 膀胱肿瘤 尼古丁 P53蛋白质 Bladder neoplasms Nicotine Protein p53
  • 相关文献

参考文献9

  • 1林华,张声,叶圣华.p^(53)过表达与胃癌患者淋巴结转移的关系[J].临床与实验病理学杂志,1996,12(2):125-127. 被引量:16
  • 2Gan J, Skipper P L, Gago-Dominguez M, et al. Alkylaniline hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst,2004,96:1425-1431.
  • 3May P, May E. Twenty years of p53 research: structural and functional aspects of p53 protein. Oncogene, 1999, 18:7621-7636.
  • 4Lane D P. Cancer p53 guardian of the genome news; comment see comment. Nature, 1992, 358:15-16.
  • 5Wang Y, Szekely L, Okan I, et al. Wild-type p53 triggred apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene, 1993, 8:3427-3431
  • 6Kirsch D G, Kastan M B. Tumor-suppressor p53: Implications for tumor development and prognosis. J Clin Oncol, 1998, 16: 3158-3168.
  • 7Cordon-Cardo C, Sheinfeld J. Molecular and immunopathlogy studies of oncogenes and tumor suppressorgenes in bladder cancer. World J Urol, 1997, 15: 112-119.
  • 8Cannon J V, Greases R, lggo R, et al. Activating mutations is p53 produce a common conformation effect: a monoclonal antibody specific the mutant form. EMBO J, 1990, 9:1595
  • 9Pfister C, Flaman J M, Martin C, et al. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors. J Urol, 1999, 161:1973-1975.

共引文献15

同被引文献38

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部